A2A Pharmaceuticals collaborates with LAXAI Life Sciences to Co-develop SARS-CoV-2 main proteases inhibitors for the treatment of COVID-19Hyderabad (Telangana) [India], June 9 (ANI/PRNewswire): A2A Pharmaceuticals, a biotechnology company committed to the advancement of innovative...